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Objective: Approximately half of all people living with amyotrophic lateral sclerosis
(ALS) experience persistent or recurrent emotional distress, yet little is known about
the psychological processes that maintain emotional distress in this population. The self-
regulatory executive functioning (S-REF) model specifies that maladaptive metacognitive
beliefs and processes are central to the development and maintenance of emotional
distress. This study explored whether maladaptive metacognitive beliefs are associated
with emotional distress after controlling for demographic factors, time since diagnosis,
and current level of physical functioning.
Design: In a cross-sectional design, 75 adults with a diagnosis of ALS completed self-
report questionnaires. Participants had a mean age of 60.40 years, mean duration of
symptoms 63.92 months, and male:female gender ratio of 14:11.
Main Outcome Measures: Questionnaires assessed emotional distress (HADS,
adapted for ALS), physical functioning (ALSFRS-R), repetitive negative thinking (RTQ-
10), metacognitive beliefs (MCQ-30), and demographic factors.
Results: Maladaptive metacognitive beliefs explained additional variance in
emotional distress after controlling for age, gender, time since diagnosis, physical
functioning, and repetitive negative thinking. Repetitive negative thinking partially
mediated the relationships between positive and negative metacognitive beliefs and
emotional distress.
Conclusions: These data support the utility of the metacognitive model in
understanding emotional distress in people with ALS. Examination of the temporal
relationship between maladaptive metacognitive beliefs and emotional distress in people
living with ALS may help to guide the development of therapeutic approaches.
Keywords: amyotrophic lateral sclerosis, distress, metacognition, repetitive negative thinking, adults
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive, incurable
neurodegenerative disorder affecting the motor neurones
(Brooks et al., 2000). It has a reported global incidence of
1–2/100,000 person-years, with an estimated 5,000 people living
with the ALS in the United Kingdom at any one time (Opie-
Martin et al., 2020). The clinical presentation, rate of progression,
and sequence of symptoms are variables, with gradual spreading
of the disease to affect the whole body [National Institute
of Neurological Disorders and Stroke (NINDS), 2013]. Key
symptoms include fasciculations, muscular weakness, atrophy,
dysphagia, dysarthria, and breathing difficulties (Talbot, 2009).
The average age of onset of ALS is 65 years (Talbot,
2009). ALS affects more males than females, with a lifetime
risk of one in 350 for males compared with one in 472 for
females in the United Kingdom (Hobson et al., 2016), but this
difference diminishes with increasing age [National Institute of
Neurological Disorders and Stroke (NINDS), 2013]. The life
expectancy for approximately 50% of people with ALS is 3 years
from symptom onset (Ilse et al., 2015), although 5–10% of people
with ALS live for 10 years or more (Chiò et al., 2013).
The cause of ALS is unknown and most cases occur
sporadically, although genetic risk factors account for around 5%
of cases (Byrne et al., 2011). Environmental exposures, lifestyle
choices, and biological ageing may contribute to causality;
however, agreement about these specific factors is lacking (Al-
Chalabi et al., 2010). The incidence of ALS is lower in Asia
than in both Europe and North America (Aktekin and Uysal,
2020). A meta-analysis reported an incidence rate of 1.89 per
100,000 in Northern Europe, compared to 0.79 per 100,000
in South Asia (Marin et al., 2017). Demographic (e.g., density
of population within at risk age), environmental, and genetic
factors may all contribute to the different incidence rates
(Aktekin and Uysal, 2020).
Some level of emotional distress is expected and
understandable in response to a diagnosis of ALS. The
unpredictable progression of ALS requires people to repeatedly
adjust to new physical limitations, which understandably can
impact on psychological well-being (Weeks et al., 2019). Severity
of distress often oscillates, although around 50% of people
with ALS experience persistent clinically significant levels of
anxiety and/or depression (McDonald et al., 1994; Ganzini
et al., 2002; Kübler et al., 2005). Anxiety and depression in
people with ALS are associated with a poorer quality of life
(Johnston et al., 1999), increased interest in hastened death
(Fang et al., 2008), and elevated suicide risk (Ganzini et al.,
2002). Clinical guidance recommends timely and effective
psychological intervention for people with ALS experiencing
depression and anxiety (National Institute for Health and
Care Excellence, 2016). However, a recent systematic review
concluded that “there is currently insufficient evidence to
recommend the use of specific psychotherapy interventions
for reducing distress or improving well-being” (pp. 293) in
this patient population (Gould et al., 2015). Moreover, the
psychological mechanisms that underlie anxiety and depression
in ALS are poorly understood (Fisher et al., 2019a).
Arguably, efficacious interventions for people with ALS
experiencing anxiety and depression must be based on a
theoretical model that can accommodate the unique needs
of this patient group. Traditional cognitive models suggest
that the content of an individual’s thoughts, beliefs, and ideas
about their health impacts upon outcomes (Becker, 1974;
Rosenstock, 1974; Leventhal et al., 1984). The Common Sense
Model (Leventhal et al., 1984) states that the relationship
between illness perceptions and outcomes is mediated by
coping strategies. Research across various health conditions has
confirmed associations for aspects of this model, for example,
diabetes (Lawson et al., 2010; Purewal and Fisher, 2018),
stroke (Pai et al., 2019), multiple sclerosis (Bassi et al., 2020),
and traumatic brain injury (Snell et al., 2013). However, a
fundamental question remains – how do illness perceptions lead
to the selection of coping strategies (Hagger et al., 2017)?
Cognitive behavioural therapy (CBT) aims to reduce
depression and anxiety by modifying illness perceptions.
Although preliminary data from a non-randomised short-term
CBT trial found a reduction in depressive and anxious symptoms
following a 4-session intervention (Díaz et al., 2016), CBT has
not been widely or rigorously evaluated in ALS. However, wider
studies indicate that CBT achieves only modest treatment effects
across physical health conditions (e.g., Wolfgang, 2013; Temple
et al., 2020), and likely is also of limited utility in ALS given that
cognitive appraisals are often accurate; for example: “I have no
control over my ALS,” “I’m not going to get better,” or “I can’t
control my symptoms.” A model and associated intervention
which focuses on how and why people respond to negative
thoughts, such as those captured by illness perceptions, may
therefore be more useful for understanding distress experienced
by people with ALS.
One such model that may offer a means to understand what
perpetuates distress in people with ALS is the transdiagnostic
self-regulatory executive function (S-REF) model (Wells and
Matthews, 1994), which underpins metacognitive therapy
(MCT). The S-REF model posits that emotional distress becomes
persistant when stored maladaptive metacognitive beliefs guide
an individual to respond to commonly occurring thoughts
and feelings in a certain way, termed the cognitive attentional
syndrome (CAS). The CAS consists of: (i) perseverative thinking
(e.g., worrying and overanalysing); (ii) attentional strategies
(e.g., monitoring for negative thoughts and feelings); and (iii)
unhelpful coping strategies (e.g., avoidance of activities). Several
types of maladaptive metacognitive belief activate and sustain the
CAS, resulting in emotional distress. Of particular importance are
“positive” maladaptive metacognitive beliefs about the usefulness
of worry (e.g., “worrying about ALS helps me to prepare for the
future”) and “negative” maladaptive metacognitive beliefs about
the uncontrollability and danger of worry (e.g., “I can’t control
my worry about ALS”). “Positive” maladaptive metacognitive
beliefs are hypothesised to indirectly cause and sustain emotional
distress by increasing an individual’s likelihood of choosing
to respond to thoughts with repetitive negative thinking. By
contrast, “negative” maladaptive metacognitive beliefs about the
uncontrollability and danger of worry are theorised to both
directly and indirectly cause and sustain emotional distress. This
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is because these beliefs are distressing and decrease the likelihood
of disengaging from repetitive negative thinking due to beliefs
that thinking cannot be controlled (Wells, 2013).
The S-REF model upon which MCT is based may offer a
particularly close “fit” to the needs of people with ALS for
several reasons. First, the model accounts for why some people
may respond to understandable negative thoughts and feelings
with perseverative thinking, attentional biases and maladaptive
coping strategies, whereas others may not. Second, MCT is
a brief intervention which targets maladaptive metacognitive
beliefs and processes. As such, it has scope to meet the specific
needs and preferences of people with ALS experiencing anxiety
and depression – namely, to help reduce distressing levels of
worry and rumination and reduce coping strategies which can
exacerbate distress (Weeks et al., 2019).
There is growing support for the clinical applicability of the
S-REF model to emotional distress in physical health conditions
(Capobianco et al., 2020)–specifically, for people with cancer
(Butow et al., 2015; Cook et al., 2015a,b), diabetes (Purewal and
Fisher, 2018), epilepsy (Fisher and Noble, 2017; Fisher et al.,
2018), multiple sclerosis (Heffer-Rahn and Fisher, 2018), chronic
fatigue syndrome (Maher-Edwards et al., 2011), fibromyalgia
(Kollmann et al., 2016), cardiovascular disease (Anderson et al.,
2019), and Parkinson’s disease (Brown and Fernie, 2015).
Preliminary evidence indicates that MCT may be an effective and
tolerable intervention for adults with physical health difficulties
(Cherry et al., 2019; Fisher et al., 2019b; McPhillips et al.,
2019). However, the utility of the S-REF model in understanding
emotional distress in people with ALS has not been studied. As
a first step toward developing more efficacious interventions for
people with ALS, this study investigates the relationships between
metacognitive beliefs, repetitive negative thinking and anxiety
and depression in people with ALS. After controlling for clinical
and demographic factors, it is hypothesised that:
1. Maladaptive metacognitive beliefs will explain
additional variance in emotional distress (anxiety and
depression) over and above that explained by repetitive
negative thinking.
2. The relationship between “positive” maladaptive
metacognitive beliefs and emotional distress will be
fully mediated by repetitive negative thinking.
3. The relationship between “negative” maladaptive
metacognitive beliefs and emotional distress will be
partially mediated by repetitive negative thinking.
MATERIALS AND METHODS
Design
The study adopted a cross-sectional design with multiple self-
report measures.
Participants
Convenience sampling methods were utilised, with participants
recruited from clinic appointments, charity branch meetings,
social media, and poster advertisements. Participants were 75
adults who met the following inclusion criteria: (i) provided
informed written consent; (ii) a self-reported diagnosis of ALS;
(iii) a self-reported absence of frontotemporal dementia; (iv)
ability to understand written English; (v) aged 18 years or over;
and (vi) completion of all study measures. Figure 1 displays the
flow of participants through the study.
Measures
Demographic and Clinical Information
A self-report questionnaire assessed age, gender, date of
diagnosis, date of symptom onset, current medications, and co-
morbid health conditions.
Emotional Distress
Emotional distress was assessed using a version of the Hospital
Anxiety and Depression Scale (HADS) (Zigmond and Snaith,
1983) adapted for people with ALS (Gibbons et al., 2011).
The adapted HADS is a 11-item self-report questionnaire in
which participants rate the presence of symptoms of anxiety
(six items) and depression (five items) over the preceding week
using a 4-point Likert scale, with options from 0 (absence) to 3
(extreme presence). Responses can be summed to produce a total
emotional distress score (HADS-T), ranging from 0 to 33, with
higher scores indicative of higher emotional distress levels. The
adapted HADS demonstrates acceptable internal consistency in
an ALS population (PSI = 0.86; Gibbons et al., 2011). Cronbach’s
alpha for the adapted HADS in the current study was 0.91.
Metacognitive Beliefs
Maladaptive metacognitive beliefs were assessed using the
Metacognitions Questionnaire-30 (MCQ-30; Wells and
Cartwright-Hatton, 2004). The MCQ-30 is a 30-item self-
report measure which assesses five maladaptive metacognitive
belief domains: (i) “positive” metacognitive beliefs; (ii) “negative”
metacognitive beliefs; (iii) cognitive confidence; (iv) need
to control thoughts; and (v) cognitive self-consciousness.
Respondents rate whether they “generally agree” with each
statement using a 4-point Likert scale, with options extending
from 1 (“do not agree”) to 4 (“agree very much”). Responses can
be summed to produce five subscale scores (ranging from six
to 24) and a total score (ranging from 30 to 120), with higher
scores indicating higher levels of unhelpful metacognitions. The
MCQ-30 subscales demonstrate adequate internal consistency
(α = 0.72–0.89; Wells and Cartwright-Hatton, 2004) and have
been used in a range of physical health populations (Cook et al.,
2014; Fisher and Noble, 2017; Fisher et al., 2018; Purewal and
Fisher, 2018). Cronbach’s alphas for the subscales in the current
study ranged from 0.66 to 0.91.
Repetitive Negative Thinking
Repetitive negative thinking was assessed using the trait version
of the Repetitive Thinking Questionnaire (RTQ-10; McEvoy et al.,
2014). The RTQ-10 is a 10-item self-report measure in which
participants rate their likelihood of responding in a certain
way to distressing situations using a 5-point Likert scale, with
options that extend from 1 (“not true at all”) to 5 (“very true”).
Responses are summed to produce a total score, ranging from
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FIGURE 1 | Participant flow diagram.
10 to 50, with higher scores indicating higher levels of repetitive
negative thinking. The RTQ-10 demonstrates acceptable internal
consistency (α ≥ 0.89; McEvoy et al., 2010). Cronbach’s alpha in
the current study was 0.92.
Physical Functioning
Physical functioning was assessed using the Self-Administered
ALS Functional Rating Scale – Revised (ALSFRS-R; Montes
et al., 2006). The ALSFRS-R is a 12-item self-report measure
designed to assess physical functioning, including bulbar, limb,
and respiratory function related to activities of daily living, in
people with ALS. Participants rate current function compared to
pre-diagnostic function on a 4-point Likert scale, with options
extending from 0 (“unable to do”) to 4 (“no change”). Responses
are summed to produce a total score, ranging from 0 to 48, with
higher scores indicating better physical functioning. The scale
has satisfactory internal consistency (α = 0.73; Cedarbaum et al.,
1999); Cronbach’s alpha for the current study was 0.87.
Procedure
Ethical approval was obtained from the Liverpool Central
Health Research Authority research and ethics committee
(Reference:16/NW/0073). Participants were recruited: (i) from
outpatient clinics at two National Health Service (NHS) hospitals
in the North of England; (ii) from branch meetings of the
Motor Neurone Disease Association (MND Association), a
United Kingdom charity for people with ALS; and (iii) online
via social media platforms of third sector organisations providing
support to people with ALS. For the NHS sites, eligible patients
attending outpatient clinic appointments were approached by
a member of their clinical team and asked to participate.
Additionally, posters were placed in clinics inviting interested
patients to speak to the researcher or their clinical team about the
study. Eligible and interested individuals could either complete
and return a study pack directly or participate online. Participants
could choose whether to complete the measures alone, with
researcher support, or with support from another trusted person.
Regardless of recruitment method, all participants were asked to
read the participant information sheet, provide informed consent
and complete the study measures, which were presented in a
random order to participants to prevent order effects.
Statistical Analysis
Raw data were first screened for inputting errors and summed
scale scores were calculated where appropriate. Missing data
were deemed to be missing at random, and therefore the
one missing value from the MCQ-30 was managed using
mean imputation (Raymond, 1986) which has demonstrated
superiority in estimating parameters (Dodeen, 2003). Data were
checked for normality of distribution; several variables showed
evidence of skewness, and therefore, correlational analyses and
Mann–Whitney U tests were used as appropriate for initial
data exploration. Hierarchical linear regression was then used to
test the hypothesis that maladaptive metacognitive beliefs would
explain additional variance in emotional distress after controlling
for basic demographics, physical functioning, and repetitive
negative thinking. Predictor variables were entered in the
following order: Step 1–age, gender; Step 2–time since diagnosis,
physical functioning; Step 3–repetitive negative thinking; Step
4–maladaptive metacognitive beliefs (all subscales). The fit of
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data within the assumptions of multiple linear regression was
assessed by examining the distribution and heteroscedasticity
of regression residuals; no violations were identified. Finally,
to test the hypothesised relationships between maladaptive
metacognitive beliefs, repetitive negative thinking and emotional
distress, two mediational analyses were conducted (Model 1:
x = “positive” maladaptive metacognitive beliefs, m = repetitive
negative thinking, y = emotional distress; Model 2: x = “negative”
maladaptive metacognitive beliefs, m = repetitive negative
thinking, y = emotional distress). In both models, age, gender,
physical functioning, and time since diagnosis were controlled
for. Bootstrapped (5,000 samples) bias-corrected and accelerated
(BCa) estimates, and 95% confidence intervals are reported for
the indirect effect (Preacher and Hayes, 2008). All analyses
were conducted in Statistical Package for Social Sciences (SPSS
version 22), with the PROCESS macro (Hayes, 2013) used
for mediational analyses; p values of < 0.05 were considered
statistically significant throughout.
Sample Size, Power, and Precision
An a priori power calculation indicated that, to adequately detect
a medium to large effect size (f 2 = 0.25) with a 0.80 power level
and a standard α level of 0.05, a minimum of 75 participants were
required for the most complex planned analysis: a multiple linear
regression containing 10 predictor variables (Faul et al., 2009).
RESULTS
Participant Demographics
Table 1 displays participants’ demographic characteristics.
Most participants were male, with a mean age of 60.40 years.
Two participants were receiving nutrition via percutaneous
endoscopic gastrostomy. Two required intubation or
tracheotomy, sixteen required non-invasive ventilation: eight
during the day and night, six during the night only, and two
intermittently. Of the sample, 22.10% met the criteria for
severe depression and 19.48% for severe anxiety (scores of
eight and above on adapted HADS-D and nine and above on
adapted HADS-A respectively; Gibbons et al., 2011). Thirty six
participants were treated with Riluzole and 25 were prescribed
an antidepressant, however, it was unclear whether this was
to treat depression or to manage symptoms of MND such as
hypersalivation through its side effects.
Preliminary Data Analysis and
Hypothesis Testing
As expected, time since diagnosis significantly negatively
correlated with ALSFRS-R score (r = −0.36). Age was
significantly correlated with cognitive confidence (r = 0.28).
There was also a significant effect of gender on cognitive
confidence, with males (Mdn = 9.50) scoring higher than females
(Mdn = 7.00), U = 524.50, z =−2.20, p = 0.03, r =−0.25. Table 2
displays inter-correlations and descriptive statistics for the
main independent (MCQ-30 subscales) and dependent (HADS-
T) variables. As expected, emotional distress was significantly
TABLE 1 | Demographic data (n = 75).
Demographic variable n (%), Unless otherwise stated




Time since onset of symptoms (months) 63.92 (64.78), 5–351a
Time since diagnosis (months) 43.61 (52.19), 1–258a
Additional health difficulties 47 (62.70)
Medication
No medication 13 (17.30)
Riluzole 23 (30.70)
Antidepressant 12 (16.00)
Riluzole and antidepressant 13 (17.30)
Other 14 (18.70)
aMean (standard deviation) and range.
positively correlated with three maladaptive metacognitive belief
domains: “negative” maladaptive metacognitive beliefs about
the uncontrollability and danger of worry (r = 0.68), cognitive
confidence (r = 0.26), and cognitive self-consciousness (r = 0.36).
Furthermore, emotional distress was also positively correlated
with repetitive negative thinking (r = 0.69). Repetitive negative
thinking was significantly positively correlated with the majority
of the MCQ subscales, apart from cognitive confidence (r values
range from 0.24 to 0.75).
Main Hypothesis Testing
Regression Analysis
The results of the regression analysis are shown in Table 3.
Hypothesis 1: Maladaptive metacognitive beliefs will
explain additional variance in emotional distress (anxiety
and depression) over and above that explained by repetitive
negative thinking.
After controlling for age, gender, and ALS characteristics,
repetitive negative thinking accounted for an additional 43%
of the variance in emotional distress. Addition of maladaptive
metacognitive belief domains explained an additional 12%
of the variance in emotional distress. The final model for
emotional distress accounted for 59% of the variance [adjusted
R2 = 0.59, F (10, 74) = 9.15, p < 0.01]. Repetitive negative
thinking and two specific maladaptive metacognitive belief
domains (positive beliefs about worry and negative beliefs about
the uncontrollability and danger of worry) made independent
contributions to the model.
Mediation of the Association Between Metacognitive
Beliefs and Emotional Distress by Repetitive
Negative Thinking
Results of the mediation analyses are shown in Figures 2, 3. Age,
gender, time since diagnosis, and physical functioning (ALSFRS-
R scores) were controlled for in both mediation models.
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TABLE 2 | Descriptive statistics and Spearman’s rho correlations between study variables.
2 3 4 5 6 7 Mdn IQR
1) HADS-T 0.69*** 0.14 0.68*** 0.26* 0.06 0.36** 9.00 5.00–14.00
2) RTQ-10 – 0.37** 0.75*** 0.19 0.24* 0.49*** 24.00 16.00–33.00
3) MCQ-PB – 0.31** 0.14 0.29* 0.28* 7.00 6.00–11.00
4) MCQ-NB – 0.12 0.21 0.57*** 10.00 6.50–14.00
5) MCQ-CC – 0.26* 0.01 8.00 6.00–11.00
6) MCQ-NC – 0.36** 9.00 8.00–12.00
7) MCQ-CSC – 14.00 11.00–16.50
HADS-T, adapted Hospital Anxiety and Depression Scale total score; IQR, interquartile range; MCQ-CC, Metacognitions Questionnaire-30 cognitive confidence
subscale; MCQ-CSC, Metacognitions Questionnaire-30 cognitive self-consciousness subscale; MCQ-NB, Metacognitions Questionnaire-30 negative beliefs about the
uncontrollability and danger of worry subscale; MCQ-NC, Metacognitions Questionnaire-30 need for control subscale; MCQ-PB, Metacognitions Questionnaire-30 positive
beliefs about worry subscale; Mdn, median; RTQ-10, Repetitive Thinking Questionnaire. *p < 0.05, **p < 0.01, and ***p < 0.001.
TABLE 3 | Hierarchical multiple linear regression model predicting emotional distress.





















































































ALSFRS, Amyotrophic Lateral Sclerosis Functional Rating Scale – Revised; dx, diagnosis; MCQ-CC, Metacognitions Questionnaire-30 cognitive confidence
subscale; MCQ-CSC, Metacognitions Questionnaire-30 cognitive self-consciousness subscale; MCQ-NB, Metacognitions Questionnaire-30 negative beliefs about the
uncontrollability and danger of worry subscale; MCQ-NC, Metacognitions Questionnaire-30 need for control subscale; MCQ-PB, Metacognitions Questionnaire-30
positive beliefs about worry subscale; RTQ-10, Repetitive Thinking Questionnaire. *p < 0.05, **p < 0.01, and ***p < 0.001. There was no evidence of multicollinearity or
autocorrelation (variance inflation factors < 10, tolerance statistics > 0.2, correlations between study variables < 0.8, Durbin–Watson test statistic of 2.18).
Hypothesis 2: The relationship between “positive”
maladaptive metacognitive beliefs and emotional distress
will be fully mediated by repetitive negative thinking.
In the mediation model assessing the role of repetitive
negative thinking in mediating the relationship between positive’
maladaptive metacognitive beliefs and emotional distress, there
was a significant indirect effect of repetitive negative thinking
(ab = 0.44, BCa 95% CIs = 0.19–0.81). There was no direct
effect, indicating full mediation. However, it should be noted that
there was a negative relationship between positive’ maladaptive
metacognitive beliefs and emotional distress.
Hypothesis 3: The relationship between “negative”
maladaptive metacognitive beliefs and emotional distress
will be partially mediated by repetitive negative thinking.
There was also a significant indirect effect in the mediation
model assessing repetitive negative thinking as a mediator of
the relationship between “negative” maladaptive metacognitive
beliefs about the uncontrollability and danger of worry and
emotional distress (ab = 0.42, BCa 95% CIs = 0.10–0.82). As with
the first model, the direct effect remained significant, indicating
partial mediation.
DISCUSSION
This was the first study to examine the association between
maladaptive metacognitive beliefs, repetitive negative thinking,
and emotional distress in an ALS population, with the aim
of testing predictions derived from the S-REF model. As
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FIGURE 2 | Mediation of positive met a cognitive beliefs on emotional distress, via Repetitive Negative Thinking. HADS-T, total adapted Hospital Anxiety and
Depression Scale score; MCQ-PB, Metacognitions Questionnaire-30 positive beliefs about worry subscale; RTQ-10, Repetitive Thinking Questionnaire; ns,
non-significant. *p < 0.05: **p < 0.01, and ***p < 0.001.
FIGURE 3 | Mediation of negative metacognitive beliefs on emotional distress, via Repetitive Negative Thinking. HADS-T, total adapted Hospital Anxiety and
Depression Scale score; MCQ-NB, Metacognitions Questionnaire-30 negative beliefs about worry subscale; RTQ-10, Repetitive Thinking Questionnaire. *p < 0.05,
**p < 0.01, and ***p < 0.001.
hypothesised, maladaptive metacognitive beliefs accounted
for an additional 12% of the variance in emotional distress
after controlling for age, gender, time since diagnosis, physical
functioning, and repetitive negative thinking. Moreover,
only repetitive negative thinking, “negative” maladaptive
metacognitive beliefs about the danger, and uncontrollability
of worry and “positive” maladaptive metacognitive beliefs
about worry made significant contributions to the final model.
This supports previous research indicating that maladaptive
metacognitive beliefs are associated with emotional distress in
individuals with physical health difficulties (Brown and Fernie,
2015; Cook et al., 2015a,b; Fisher and Noble, 2017; Heffer-Rahn
and Fisher, 2018; Purewal and Fisher, 2018) and reflects previous
findings that physical functioning, time since diagnosis, and
demographic factors are inconsistent predictors of emotional
distress in people with ALS (De groot et al., 2007; Gauthier et al.,
2007; Cupp et al., 2011; Matuz et al., 2015; Fisher et al., 2019b).
Mediational analyses largely supported the hypothesised
relationships between maladaptive metacognitive beliefs,
repetitive negative thinking and emotional distress. As expected,
the relationship between “negative” maladaptive metacognitive
beliefs and emotional distress was partially mediated by repetitive
negative thinking, which is consistent with both the main thesis
of the S-REF model and the findings of previous research (Cook
et al., 2015a,b; Heffer-Rahn and Fisher, 2018). However, the
relationship between “positive” maladaptive metacognitive
beliefs and emotional distress was only partially mediated by
repetitive negative thinking. Furthermore, “positive” maladaptive
metacognitive beliefs were negatively associated with emotional
distress. Although this supports the thesis that “positive”
maladaptive metacognitive beliefs act indirectly to cause and
sustain emotional distress by promoting the use of worry
and rumination as maladaptive coping strategies, the negative
relationship between “positive” maladaptive metacognitive
beliefs is not clearly understood. It may be that the perceived
helpfulness of thinking about difficulties provides a sense of
control and ability to cope in the short-term, therefore reducing
emotional distress (Hayes et al., 2006). However, when “positive”
maladaptive metacognitive beliefs lead to the selection of
persistent repetitive negative thinking as a coping strategy, this
results in emotional distress. This is clearly an area that would,
benefit from further research.
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LIMITATIONS AND FUTURE RESEARCH
DIRECTIONS
There are several limitations to this study which may influence
the generalisability of findings. First, the study was cross-sectional
and therefore causality cannot be assumed. Second, consideration
of unmeasured variables, such as social support or psychological
support (Goldstein et al., 2006; Matuz et al., 2015), may have
resulted in a more robust model that was able to account for a
larger proportion of the variance.
Third, various adjustments were made to improve accessibility
for patients in a hard to reach group, which limited the reliability
and detail of data collected. Given these encouraging initial
findings, tests of the S-REF model could be applied to other
forms of emotional distress e.g., traumatic stress symptoms.
The S-REF model could be tested in its entirety e.g., through
the including assessment of threat monitoring e.g., feelings of
distress and presence of negative thoughts (illness perceptions).
People with comorbid physical health conditions and clinical
levels of emotional distress often using counterproductive coping
strategies (e.g., trying not to have negative thoughts, thinking
positively, or trying to avoid situations or events which may
trigger worry and rumination). All these domains should
be assessed in future tests of the S-REF model, as well as
objectively verifying key clinical variables such as frontotemporal
dementia and diagnosis of ALS. Objective verification is
particularly important for frontotemporal dementia diagnosis,
given altered insight into deficits is a key clinical feature
(Muñoz-Neira et al., 2019).
Finally, although all analyses were adequately powered
(post hoc power for both final regression models = 0.80; p = 0.05),
the sample size was modest and may not generalise to the
ALS population. There were few individuals receiving nutrition
via percutaneous endoscopic gastrostomy or required assisted
ventilation and there was a greater duration of disease, compared
to the general ALS population (Ilse et al., 2015). Future testing
of the model in a larger, more representative sample of people
with ALS would allow for more detailed testing of the S-REF
model through subgroup analyses (e.g., grouping individuals
based on time since diagnosis or site of onset). However,
it should be recognised that recruiting and retaining people
with ALS with severe symptoms in research studies can be
challenging given poor health and prioritisation of end of life
needs (Albert et al., 2005).
To translate interventions, longitudinal multi-site designs
are required to test the causal role of metacognitive beliefs in
emotional distress experienced by people with ALS. Despite
the difficulties associated with conducting longitudinal research
in this population, consideration of ALS-specific factors could
further our understanding of the S-REF model in this population.
These may include the relationship of perceived ability to
communicate effectively with the level of repetitive negative
thinking or the influence of social cognition change on theory
of mind and emotional distress (van der Hulst et al., 2015).
Such research could potentially support identification and
implementation of support for those at risk of developing
emotional distress. Future research should also take a between-
group approach and consider how metacognitive beliefs present
in those who adapt well to ALS, how they respond to thoughts,
the coping strategies this leads them to adopt, and how this
impacts on their psychological wellbeing. Examples of adaptive
metacognitive beliefs in this population might include “I can
choose whether to engage with my thoughts about ALS,” and “I
can manage my worries, they will pass.” The S-REF model posits
that these beliefs would result in an ability to disengage from
thoughts and subsequently lowered distress levels; this would be
a valuable hypothesis to explore further.
CONCLUSION
In summary, our findings indicate that maladaptive
metacognitive beliefs and repetitive negative thinking are
strongly associated with emotional distress in people with ALS
and account for substantial variance in emotional distress and
after controlling for demographic and clinical factors. This is in
keeping with findings of other studies examining the fit of the
S-REF model in physical health populations (Capobianco et al.,
2020). If tailored to the needs of people with ALS, MCT could be
an acceptable psychological intervention. Better understanding
of metacognitive beliefs and processes in this population may
provide a basis for investigating the efficacy of MCT for reducing
depression and anxiety in people with ALS.
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